Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Clinical Selection Strategies to Identify Ischemic Stroke Patients With Large Anterior Vessel Occlusion: Results From SITS-ISTR (Safe Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry).
Jan F. Scheitz,Azmil H. Abdul-Rahim,Rachael L. MacIsaac,Charith Cooray,Heidi Sucharew,Dawn Kleindorfer,Pooja Khatri,Joseph P. Broderick,Heinrich J. Audebert,Niaz Ahmed,Nils Wahlgren,Matthias Endres,Christian H. Nolte,Kennedy R. Lees +13 more
TL;DR: Simple modification of the face–arm–speech–time score or evaluating the NIHSS symptom profile may help to stratify patients’ risk of LAVO and to identify individuals who deserve rapid transfer to comprehensive stroke centers.
127
A randomised, controlled pilot study to investigate the potential benefit of intervention with insulin in hyperglycaemic acute ischaemic stroke patients.
TL;DR: Glycaemic control with sliding scale insulin for 48 h is feasible and well-tolerated after AIS and treatment after 48 h may be unnecessary.
127
Initial Experience of a Digital Training Resource for Modified Rankin Scale Assessment in Clinical Trials
TL;DR: Certification results suggest that use of the mRS training resource can improve mRS grading, and outline the development of a video-based training package, including technical issues, patient selection procedures, and methods of scoring and assessment.
126
Thrombolysis in Stroke Despite Contraindications or Warnings
Benedikt Frank,James C. Grotta,Andrei V. Alexandrov,Erich Bluhmki,Patrick D. Lyden,Atte Meretoja,Nishant K. Mishra,Ashfaq Shuaib,Nils Wahlgren,Christian Weimar,Kennedy R. Lees +10 more
TL;DR: adjusted odds ratios showed a broad trend of more favorable 3-month outcome associated with alteplase treatment versus no treatment in various subgroups of patients with contraindications and warnings, which provides reassurance about benefits and risks of intravenous altePLase treatment in common clinical situations.
125
Excitatory amino acid antagonists for acute stroke.
Keith W. Muir,Kennedy R. Lees +1 more
TL;DR: There was no significant heterogeneity of outcome amongst individual drugs, or of drug classes either for the primary efficacy analysis (death or dependence) or for mortality at final follow-up, and no statistically significant detriment of psychotomimetic NMDA antagonists was found.